TheRealJavierNovoa
TheRealJavierNovoa @JNOVOA1985 ·
Invest in canned food if you can, or dried food, while prices are still accesible. Worse case scenario you will have canned food you don't need immediately, and you can have some cheap meals. #food #foodstorage #prep #oil #iran
11
MasaTHB
MasaTHB @MasaTHB ·
ギャルが遊びに来た午前。 掃除しまくってレコードなんか掛けてるいけてるさたでえ 甘い声大好きなんすよねぇ タイの人も好きよねぇ #prep
28
CME Outfitters
CME Outfitters @cmeoutfitters ·
HIV prevention is evolving—and so are PrEP options. Stay current on efficacy, safety, and long-acting injectable therapies. 👉cmeo.me/SN-306U #HIV #PrEP #HIVPrevention #MedEd
Staying Current – Navigating the Latest Advances in PrEP Options

As HIV prevention strategies continue to evolve, healthcare professionals across the globe face persistent knowledge gaps in evaluating and integrating the latest pre-exposure prophylaxis (PrEP)...

From cmeoutfitters.com
17
Bhekisisa
Bhekisisa @Bhekisisa_MG ·
SA approved a 2-monthly HIV prevention jab in 2022. It never reached public clinics. Now a better, cheaper jab is taking its place. Here's what happened to CAB-LA. #HIV #PrEP bhekisisa.org/article/2026-0…
CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives -...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit...

From bhekisisa.org
117
HOPE worldwide Kenya
HOPE worldwide Kenya @HOPEwwKenya ·
Yesterday, HOPE worldwide Kenya joined Nakuru County & partners to celebrate the launch of long-acting injectable #PrEP: Lenacapavir (2× yearly) and Cabotegravir (every 2 months). A major step forward in expanding HIV prevention choices. #JipendeJiprep
1
33
Bhekisisa
Bhekisisa @Bhekisisa_MG ·
Cabotegravir was the front end of our learning about long-acting injectables. It was an investment. It wasn't a waste. — Mitchell Warren, @HIVpxresearch. #HIV #PrEP #LEN #CAB-LA bhekisisa.org/article/2026-0…
CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives -...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit...

From bhekisisa.org
51
Life4me+ по-русски
Life4me+ по-русски @life4meplus_ru ·
В проектах с контролируемым приемом препарата эффективность достигала 92%, а при сравнении форм лечения снижение риска варьировало от 66% до 89% между инъекционной и пероральной схемой. #PrEP #ВИЧ life4me.plus/ru/news/vich-1…
Эффективность доконтактной профилактики ВИЧ в различных группах риска: систематический обзор

Исследование показало, что снижение риска получения ВИЧ при PrEP колеблется от 49% до 86% в различных группах. Согласно результатам, среди участников, у которых зафиксировано регулярное применение...

From life4me.plus
24